Assistant Professor - medical
Strategic program(s):
Research aim
Our research aims to revolutionise cancer treatment by advancing innovative immunotherapies, ensuring safer, more effective therapies, and improving patient outcomes, ultimately transforming lives through cutting-edge translational cancer research.
Go to groupHematoloog - Spreker en moderator DHC - NVVH
Spreker - Overzicht MPN ontwikkelen ASH voor Nederland - HED & ASH Revies
bestuurslid - werkgroep - HOVON
Lid - Werkgroep - HOVON MPN werkgroep
Lid - Member Registry Committee - EBMT
Member - Data Safety Monitoring Board Miltenyi DALY trials - Miltenyi
Lid - organisatie DHC congres - NVVH